- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02272829
Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain (CHOACOT)
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Up to 20% of HIV patients receive prescriptions for chronic opioid therapy (COT) to treat chronic pain. This project will develop a novel collaborative treatment, based on the primary care behavioral consultation model and behavior therapy techniques including motivational interviewing and functional assessment, in which a patient, a Behavioral Health Consultant and a HIV primary care provider share a unified plan targeting misuse of prescribed opioid analgesics in older HIV+ adults. This would be the first theoretically-driven, empirically-tested intervention that specifically attends to the difficult issues around chronic pain and opioid prescription in HIV clinical practice.
This project will develop a collaborative, brief, behavioral consultation intervention targeting misuse of prescribed opioids in older HIV+ adults. The intervention, CHOACOT (Consultation for HIV+ Older Adults on Chronic Opioid Therapy), will consist of:
- three meetings between the Behavioral Health Specialist (BHS) and the patient
- two brief consultations between the BHC and the HIV-PCP
- a joint meeting of the patient, BHC, and HIV-PCP.
To achieve our aims, we will develop CHOACOT beginning with an iterative open trial (n=10). Next, we will conduct a pilot randomized clinical trial (n=30) of CHOACOT versus enhanced Treatment-As-Usual. Opioid misuse will be the primary outcome variable. Quality of the patient-provider relationship, pain, problematic use of other substances, antiretroviral adherence, and psychosocial functioning will be secondary outcomes. The specific aims are:
Aim 1. Develop and refine CHOACOT so that it meets standards of feasibility and acceptability for HIV PCPs, BHCs, and participants;
1a. To develop and field test a CHOACOT BHC manual;
1b. To develop a reliable measure of BHC manual adherence;
1c. To develop and field-test BHC training and supervision procedures. Aim 2. Refine research procedures (e.g., consent and randomization processes, assessment procedures), and establish their feasibility and acceptability to participants while confirming recruitment goal targets.
Misuse of prescribed opioids is the primary outcome. Secondary outcomes are problematic use of substances with a high potential for lethality when used with COT (benzodiazepines, cocaine, alcohol, heroin), ARV adherence, viral load, pain, psychosocial functioning, patient-provider alliance, and treatment satisfaction and acceptability.
This line of work could lead to the incorporation into HIV care of a theoretically-driven and empirically-tested brief intervention for older HIV patients who are prescribed opioids for chronic pain and for whom there is concern about opioid misuse.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02906
- Butler Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- HIV patients with a physician at the enrollment site;
- Age 50 or older;
- Chronic pain (pain duration for at least six months);
- Daily use of an opioid analgesic, prescribed by an HIV-PCP at the study site, for at least the past 90 days;
- Patients endorse "feeling at risk of losing their pain medication prescription," or that they are "unhappy with how they and their doctors are working together to manage their pain";
- Patient-rated Addictions Behavior Checklist score > 3, as a recommended cut-point indicating opioid misuse.
Exclusion Criteria:
- Current, severe psychiatric symptoms requiring immediate clinical attention;
- Inability to understand English;
- Cognitive impairment severe enough to interfere with ability to actively participate in CHOACOT.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Active
Participants in this arm will receive the study intervention (sessions with the BHC and the PCP).
|
This is an intervention for individuals who use opioid medication for chronic pain, and targets the collaboration between the participant and his/her PCP.
|
|
Placebo komparator: Health Education
Participants in this arm will receive study sessions about various health topics.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
opioid use
Tidsramme: 4 months
|
opioid use will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
quality of the patient-provider relationship
Tidsramme: 4 months
|
quality of the patient-provider relationship will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
|
pain
Tidsramme: 4 months
|
pain will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
|
problematic use of other substances
Tidsramme: 4 months
|
problematic use of other substances will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
|
antiretroviral adherence
Tidsramme: 4 months
|
antiretroviral adherences will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
|
psychosocial functioning
Tidsramme: 4 months
|
psychosocial functioning will be assessed, through self-report measures, monthly over the course of the 4-month study participation period
|
4 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Michael Stein, MD, Butler Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Psykiske lidelser
- Kjemisk-induserte lidelser
- Stoffrelaterte lidelser
- Smerte
- Nevrologiske manifestasjoner
- Narkotikarelaterte lidelser
- Kronisk smerte
- Opioidrelaterte lidelser
- Fysiologiske effekter av legemidler
- Sentralnervesystemdepressiva
- Agenter fra det perifere nervesystemet
- Analgetika
- Sensoriske systemagenter
- Narkotika
- Analgetika, opioid
Andre studie-ID-numre
- DA038203
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på HIV
-
Duke UniversityGilead SciencesRekrutteringHIV-forebygging | HIV Pre-eksponeringsprofylakse | HIV-forebyggingsprogram | HIV-forebygging og omsorg | HIV Pre-eksponering profylakse brukForente stater
-
Federal University of São PauloGilead SciencesFullført
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutteringHIV | HIV-testing | HIV-kobling til omsorg | HIV-behandlingForente stater
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RekrutteringPrEP | HIV | HIV-forebygging | PrEP-opptakForente stater
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationFullførtPartner HIV-testing | Par HIV-rådgivning | Parkommunikasjon | HIV-forekomstKamerun, Den dominikanske republikk, Georgia, India
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RekrutteringHIV-forebygging | PrEP Overholdelse | Stigma knyttet til HIVThailand
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RekrutteringGjennomførbarhet | HIV-forebygging | PrEP-opptak | Akseptabilitet | HIV Selvtesting | Mannlige partnere av HIV-negative postpartum kvinnerSør-Afrika
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement og andre samarbeidspartnereUkjentHIV | HIV-uinfiserte barn | Barn utsatt for HIVKamerun
-
Instituto Mexicano del Seguro SocialRekrutteringVekttap | HIV | HIV-1 infeksjon | Vektendring | HIV Associate Vekttap | Integrasehemmere, HIV; HIV PROTEASE HEMMINGMexico
-
University of MinnesotaTilbaketrukketHIV-infeksjoner | HIV/AIDS | Hiv | AIDS | Aids/Hiv problem | AIDS og infeksjonerForente stater
Kliniske studier på Helse utdanning
-
Chang Gung University of Science and TechnologyChang Gung Memorial Hospital; National Science and Technology CouncilFullført
-
Federal University of PelotasAktiv, ikke rekrutterende
-
London School of Hygiene and Tropical MedicineMedical Research Council Unit, The Gambia; Nova Scotia Gambia Association... og andre samarbeidspartnereFullført
-
Cairo UniversityFullførtOral sykdom | Gingival sykdomEgypt
-
Universiti Putra MalaysiaRekruttering
-
Abant Izzet Baysal UniversityRekrutteringType 1 diabetes | Bare barnTyrkia (Türkiye)
-
Chia-Tzu LineFullførtType 2 diabetes mellitus (T2DM) | Diabetespasienter, egenomsorg, kunstig intelligensbasert, egeneffektivitetKina
-
University of UtahNational Institutes of Health (NIH); National Center for Advancing Translational...FullførtHelsekunnskap, holdninger, praksisForente stater
-
Guangzhou University of Traditional Chinese MedicineUkjentFor å undersøke forholdet mellom overholdelse av HHEP etter ISTIA og tilbakefall av hjerneslag eller kardiovaskulære hendelser.Kina
-
University of North Carolina, Chapel HillFullført